B+
Bull case
25%
Probability
Target price
$38.85
+49.7% vs current
Analyst coverage clusters in the low‑to‑mid $30s (median ~31.15), implying modest upside vs. the current anchor. Market tone is neutral-to-cautious ahead of near-term earnings, with conviction hinging on execution and guidance.
No evidence quality warning is currently attached to this memo.
Quarterly results and guidance are the immediate catalyst; with sparse consensus, beats/raises or weak guidance can move the stock materially.
Analyst target dispersion implies upside if program wins or demand recovery materialize; downward revisions would compress valuation.
No formal recommendation provided.